Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of a booster dose of the Japanese encephalitis vaccine IC51 on long-term immunogenicity
2007-002793-64Phase 3Completed
- Sponsor
- Intercell AG
- Start
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of japanese encephalitis vaccine (inactivated, adsorbed) in Japanese encephalitis (JE), sponsored by Intercell AG. Started Sep 2007; status: completed.
02
Drugs
japanese encephalitis vaccine (inactivated, adsorbed)
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2007-002793-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002793-64.